Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

The decrease in breast-cancer incidence in 2003 in the United States.

Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA.

N Engl J Med. 2007 Apr 19;356(16):1670-4.

2.

Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.

Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK.

J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. Review. Erratum in: J Natl Cancer Inst. 2003 Nov 5;95(21):1641.

3.

The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.

Verkooijen HM, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman M.

Maturitas. 2009 Oct 20;64(2):80-5. doi: 10.1016/j.maturitas.2009.07.015. Epub 2009 Aug 25. Review.

PMID:
19709827
4.

Use of HRT and the subsequent risk of cancer.

Beral V, Banks E, Reeves G, Appleby P.

J Epidemiol Biostat. 1999;4(3):191-210; discussion 210-5. Review.

PMID:
10695959
5.

Socioeconomic factors and breast carcinoma in multicultural women.

Baquet CR, Commiskey P.

Cancer. 2000 Mar 1;88(5 Suppl):1256-64. Review.

PMID:
10705364
6.

Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy?

Gompel A, Plu-Bureau G.

Ann N Y Acad Sci. 2010 Sep;1205:268-76. doi: 10.1111/j.1749-6632.2010.05664.x. Review.

PMID:
20840283
7.

The "epidemic" of breast cancer in the U.S.--determining the factors.

King SE, Schottenfeld D.

Oncology (Williston Park). 1996 Apr;10(4):453-62; discussion 462, 464, 470-2. Review.

Items per page

Supplemental Content

Write to the Help Desk